Steven Cohen’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.01M Buy
11,500
+1,600
+16% +$410K ﹤0.01% 2157
2026
Q2
$2.49M Sell
9,900
-12,600
-56% -$2.71M ﹤0.01% 2245
2026
Q1
$4.89M Sell
22,500
-6,800
-23% -$1.51M 0.01% 1717
2025
Q4
$6.69M Buy
+29,300
New +$6.67M 0.01% 1612
2025
Q2
– Sell
-70,000
Closed -$14.7M – 2127
2025
Q1
$14.7M Buy
+70,000
New +$13.6M 0.03% 543
2021
Q2
– Sell
-100,000
Closed -$10.8M – 943
2021
Q1
$10.8M Buy
+100,000
New +$10.7M 0.05% 408
2018
Q4
– Sell
-187,900
Closed -$17.8M – 925
2018
Q3
$17.8M Buy
+187,900
New +$17.8M 0.07% 329

Other funds holding ABBV

Steven Cohen's ABBV Position: Q3 2026 in Review

Steven Cohen sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 366,836 shares — an estimated $94M sold.

Steven Cohen first reported a position in ABBV in Q3 2014 and held it in 20 quarters. The position peaked at $164M in Q1 2023. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Steven Cohen reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 366,836 AbbVie shares in Q3 2026, an estimated $94M.
  • Steven Cohen first reported a position in AbbVie in Q3 2014 and held it in 20 quarters.
  • Steven Cohen's AbbVie position peaked at $164M in Q1 2023.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.